Efficacy of insulin degludec in young persons with Type 1 diabetes after switching from insulin glargine or insulin detemir HL Tan and

被引：0
|
作者：
Tan, H. L. [1 ]
Chau, F. [1 ]
机构：
[1] North Bristol NHS Trust, Bristol, Avon, England
来源：
DIABETIC MEDICINE | 2016年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P246
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [11] An Open-label Longitudinal Study on the Efficacy of Switching from Insulin Glargine or Detemir to Degludec in Type 2 Diabetes Mellitus
    Kanazawa, Ippei
    Notsu, Masakazu
    Tanaka, Ken-ichiro
    Kiyohara, Nobuaki
    Tada, Yuko
    Sugimoto, Toshitsugu
    INTERNAL MEDICINE, 2015, 54 (13) : 1591 - 1598
  • [12] Comparison of Insulin Glargine with Insulin Degludec in Type 1 Diabetes Patients
    Kuroda, Akio
    Tsuruo, Miho
    Takeshi, Kondo
    Aki, Nanako
    Oguro, Yukari
    Endo, Itsuro
    Aihara, Ken-ichi
    Tamaki, Motoyuki
    Matsumoto, Toshio
    Matsuhisa, Munehide
    DIABETES, 2014, 63 : A232 - A232
  • [13] EFFICACY AND SAFETY OF SWITCHING FROM INSULIN DETEMIR TO INSULIN DEGLUDEC WITH MEALTIME INSULIN ASPART IN PEDIATRIC PATIENTS WITH TYPE 1 DIABETES. AN OBSERVATIONAL PROSPECTIVE STUDY
    Elbarbary, Nancy S.
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 45 - 45
  • [14] A 1-year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal-bolus insulin therapy (Kumamoto Insulin Degludec Observational study)
    Shimoda, Seiya
    Sato, Miki
    Sekigami, Taiji
    Motoshima, Hiroyuki
    Yoshimura, Ryohei
    Fukuda, Kazuki
    Matsuo, Yasuto
    Noda, Hideyuki
    Okubo, Mina
    Ichimori, Shinji
    Fujisawa, Kazuo
    Fukunaga, Makiko
    Araki, Eiichi
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (05) : 703 - 710
  • [15] Insulin degludec is associated with less frequent and milder hypoglycemia in insulin-deficient patients with type 1 diabetes compared with insulin glargine or detemir
    Iwasaki S.
    Kozawa J.
    Kimura T.
    Fukui K.
    Iwahashi H.
    Imagawa A.
    Shimomura I.
    Diabetology International, 2017, 8 (2) : 228 - 236
  • [16] Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Simon, A. C. R.
    Swinnen, S. G.
    Holleman, F.
    Hoekstra, J. B. L.
    DeVries, J. H.
    DIABETOLOGIA, 2011, 54 : S420 - S421
  • [17] Insulin detemir versus insulin glargine for type 2 diabetes mellitus
    Swinnen, Sanne G.
    Simon, Airin C. R.
    Holleman, Frits
    Hoekstra, Joost B.
    DeVries, J. Hans
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (07):
  • [18] Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy
    Pieber, T. R.
    Treichel, H- C.
    Hompesch, B.
    Philotheou, A.
    Mordhorst, L.
    Gall, M- A.
    Robertson, L. I.
    DIABETIC MEDICINE, 2007, 24 (06) : 635 - 642
  • [19] Deleterious Outcomes after Abrupt Transition from Insulin Glargine to Insulin Detemir in Patients with Type 1 Diabetes Mellitus
    Kabadi, Udaya M.
    CLINICAL DRUG INVESTIGATION, 2008, 28 (11) : 697 - 701
  • [20] Deleterious Outcomes after Abrupt Transition from Insulin Glargine to Insulin Detemir in Patients with Type 1 Diabetes Mellitus
    Udaya M. Kabadi
    Clinical Drug Investigation, 2008, 28 : 697 - 701
12345